168 related articles for article (PubMed ID: 20182437)
1. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.
Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V
J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
Aghai ZH; Faqiri S; Saslow JG; Nakhla T; Farhath S; Kumar A; Eydelman R; Strande L; Stahl G; Leone P; Bhandari V
J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants.
Mody K; Saslow JG; Kathiravan S; Eydelman R; Bhat V; Stahl GE; Pyon K; Bhandari V; Aghai ZH
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1483-7. PubMed ID: 22272724
[TBL] [Abstract][Full Text] [Related]
4. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates.
Ambalavanan N; Novak ZE
Pediatr Res; 2003 Feb; 53(2):240-4. PubMed ID: 12538781
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
Yanamandra K; Boggs P; Loggins J; Baier RJ
Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510
[TBL] [Abstract][Full Text] [Related]
7. Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation.
Thomas W; Seidenspinner S; Kawczyńska-Leda N; Chmielnicka-Kopaczyk M; Marx A; Wirbelauer J; Szymankiewicz M; Speer CP
Neonatology; 2010; 97(3):228-34. PubMed ID: 19887851
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.
Aghai ZH; Saslow JG; Mody K; Eydelman R; Bhat V; Stahl G; Pyon K; Bhandari V
Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.
Baier RJ; Loggins J; Kruger TE
BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236
[TBL] [Abstract][Full Text] [Related]
10. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
11. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia.
Kakkera DK; Siddiq MM; Parton LA
Biol Neonate; 2005; 87(2):82-90. PubMed ID: 15539764
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
14. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
15. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
Cogo PE; Zimmermann LJ; Pesavento R; Sacchetto E; Burighel A; Rosso F; Badon T; Verlato G; Carnielli VP
Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
17. Lower parathyroid hormone-related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia.
Rehan VK; Torday JS
Pediatr Res; 2006 Aug; 60(2):216-20. PubMed ID: 16864707
[TBL] [Abstract][Full Text] [Related]
18. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
Forest S
J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
[TBL] [Abstract][Full Text] [Related]
19. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia.
Kim BI; Lee HE; Choi CW; Jo HS; Choi EH; Koh YY; Choi JH
J Perinat Med; 2004; 32(3):282-7. PubMed ID: 15188806
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
